Français
ItalianoBond Royalty Pharma 1.2% ( USG7709QAB08 ) in USD
| Issuer | Royalty Pharma | ||||||||||||
| Market price | 99.62 % ▲ | ||||||||||||
| Country |  United Kingdom
|
||||||||||||
| ISIN code |
 USG7709QAB08 ( in USD )
|
||||||||||||
| Interest rate | 1.2% per year ( payment 2 times a year) | ||||||||||||
| Maturity | 02/09/2025 - Bond has expired | ||||||||||||
|
Prospectus brochure in PDF format |
|||||||||||||
| Minimal amount | 2 000 USD | ||||||||||||
| Total amount | 1 000 000 000 USD | ||||||||||||
| Cusip | G7709QAB0 | ||||||||||||
| Standard & Poor's ( S&P ) rating | BBB- ( Lower medium grade - Investment-grade ) | ||||||||||||
| Detailed description |
Royalty Pharma is a biopharmaceutical company that invests in and manages royalties from marketed pharmaceutical and biotechnology products. The Bond issued by Royalty Pharma ( United Kingdom ) , in USD, with the ISIN code USG7709QAB08, pays a coupon of 1.2% per year. The coupons are paid 2 times per year and the Bond maturity is 02/09/2025 The Bond issued by Royalty Pharma ( United Kingdom ) , in USD, with the ISIN code USG7709QAB08, was rated BBB- ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||||||
| |||||||||||||